An Open-labeled Trial of Ramipril in Patients With Migraine

Update Il y a 4 ans
Reference: NCT01402479

Woman and Man

Extract

Physiology of migraine involving renin-angiotensin systems (RAS) has been implicated. Ramipril is a broadly-used angiotensin-converting enzyme inhibitor. The investigators attempt to test the efficacy of ramipril on the prophylaxis of migraine attacks.


Inclusion criteria

  • Migraine With Hypertension

Links